ChemR23-IN-2 is primarily used in research settings to study its potential as a therapeutic agent targeting the ChemR23 receptor, which is implicated in various inflammatory and metabolic processes. It is explored for its ability to modulate immune responses, making it a candidate for treating conditions like rheumatoid arthritis, atherosclerosis, and other chronic inflammatory diseases. Additionally, its role in regulating lipid metabolism and insulin sensitivity is being investigated, suggesting potential applications in managing metabolic disorders such as obesity and type 2 diabetes. Researchers also utilize ChemR23-IN-2 to better understand the signaling pathways associated with the ChemR23 receptor, aiding in the development of novel drugs for related health conditions.